Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02391714 · ClinicalTrials.gov registry record · NA

Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion

A NA study, sponsored by University of New Mexico.

Completed
Registry status
NA
Development phase
80
Enrollment target

NCT02391714: Completed NA study, sponsored by University of New Mexico.

NCT02391714 is a NA study that has completed, run by University of New Mexico. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02391714, a NA study, has completed, sponsored by University of New Mexico.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether Nitrous Oxide is effective in achieving pain control and satisfaction among nulliparous women getting the intrauterine device (IUD).

Primary Outcome

Pain is assessed using a 0-100mm VAS with anchors 0 equals no pain and 100 equals worst pain imaginable. The minimal clinically important difference in pain for this study was set at 15mm.

Interventions

  • DRUG Povidone-Iodine
  • OTHER Oxygen
  • DRUG Chlorhexidine
  • PROCEDURE IUD insertion
  • OTHER Nitrous oxide

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-10
Est. Completion 2014-08
Phase NA
University of New Mexico

168 total trials

What the finished NCT02391714 record still lists

NCT02391714 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 5 interventions - of which Povidone-Iodine is the first listed.

NCT02391714 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02391714 about?

NCT02391714 is a clinical study titled "Nitrous Oxide for Pain Management of Intrauterine Device (IUD) Insertion". The purpose of this study is to determine whether Nitrous Oxide is effective in achieving pain control and satisfaction among nulliparous women getting the intrauterine device (IUD).

What is the current status of trial NCT02391714?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2013-10. Estimated completion is 2014-08.

What interventions are being tested in trial NCT02391714?

The interventions under investigation include: Povidone-Iodine (DRUG), Oxygen (OTHER), Chlorhexidine (DRUG), IUD insertion (PROCEDURE), Nitrous oxide (OTHER).

Who is sponsoring clinical trial NCT02391714?

This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02391714's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02391714, the US trial registry maintained by the National Library of Medicine. NCT02391714 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.